{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T23:07:45Z","timestamp":1788476865228,"version":"build-2803163510"},"reference-count":55,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T00:00:00Z","timestamp":1537833600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.02209","type":"journal-article","created":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T04:42:29Z","timestamp":1537850549000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":48,"title":["IL-22: An Underestimated Player in Natural Resistance to Tuberculosis?"],"prefix":"10.3389","volume":"9","author":[{"given":"Katharina","family":"Ronacher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roma","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Cestari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,9,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e1002152","DOI":"10.1371\/journal.pmed.1002152","article-title":"The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling","volume":"13","author":"Houben","year":"2016","journal-title":"PLoS Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/nrmicro2236","article-title":"The spectrum of latent tuberculosis: rethinking the biology and intervention strategies","volume":"7","author":"Barry","year":"2009","journal-title":"Nat Rev Microbiol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"e64","DOI":"10.1016\/S1473-3099(17)30623-0","article-title":"Genetics of human susceptibility to active and latent tuberculosis: present knowledge and future perspectives","volume":"18","author":"Abel","year":"2018","journal-title":"Lancet Infect Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"S1438","DOI":"10.1016\/j.ijmm.2017.09.009","article-title":"Shaping the niche in macrophages: genetic diversity of the M","author":"Reiling","year":"2017","journal-title":"Int J Med Microbiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/imr.12257","article-title":"Acquired immunodeficiencies and tuberculosis: focus on HIV\/AIDS and diabetes mellitus","volume":"264","author":"Ronacher","year":"2015","journal-title":"Immunol Rev."},{"key":"B6","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.cytogfr.2006.09.001","article-title":"Interleukin-22: a novel T- and NK-cell derived cytokine that regulates the biology of tissue cells","volume":"17","author":"Wolk","year":"2006","journal-title":"Cytokine Growth Factor Rev."},{"key":"B7","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s00011-013-0608-1","article-title":"Interleukin-22 produced by alveolar macrophages during activation of the innate immune response","volume":"62","author":"Hansson","year":"2013","journal-title":"Inflamm Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1002\/eji.201646723","article-title":"IL-17 and IL-22 in immunity: driving protection and pathology","volume":"47","author":"Eyerich","year":"2017","journal-title":"Eur J Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.4049\/jimmunol.1601480","article-title":"Th22 cells form a distinct Th lineage from Th17 Cells in vitro with unique transcriptional properties and Tbet-dependent Th1 plasticity","volume":"198","author":"Plank","year":"2017","journal-title":"J Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00281-009-0188-x","article-title":"Biology of interleukin-22","volume":"32","author":"Wolk","year":"2010","journal-title":"Semin Immunopathol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.immuni.2004.07.007","article-title":"IL-22 increases the innate immunity of tissues","volume":"21","author":"Wolk","year":"2004","journal-title":"Immunity"},{"key":"B12","doi-asserted-by":"publisher","first-page":"16006","DOI":"10.1074\/jbc.M611040200","article-title":"The interleukin-22\/STAT3 pathway potentiates expression of inducible nitric-oxide synthase in human colon carcinoma cells","volume":"282","author":"Ziesche","year":"2007","journal-title":"J Biol Chem."},{"key":"B13","doi-asserted-by":"publisher","first-page":"6639","DOI":"10.4049\/jimmunol.0902587","article-title":"IL-22 produced by human NK cells inhibits growth of Mycobacterium tuberculosis by enhancing phagolysosomal fusion","volume":"183","author":"Dhiman","year":"2009","journal-title":"J Immunol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"190","DOI":"10.4049\/jimmunol.1004129","article-title":"Membrane-bound IL-22 after de novo production in tuberculosis and anti-Mycobacterium tuberculosis effector function of IL-22+ CD4+ T cells","volume":"187","author":"Zeng","year":"2011","journal-title":"J Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/mi.2017.15","article-title":"Novel role for IL-22 in protection during chronic Mycobacterium tuberculosis HN878 infection","volume":"10","author":"Treerat","year":"2017","journal-title":"Mucosal Immunol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nm1710","article-title":"IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia","volume":"14","author":"Aujla","year":"2008","journal-title":"Nat Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1165\/rcmb.2003-0285OC","article-title":"Interleukin-22: a potential immunomodulatory molecule in the lung","volume":"31","author":"Whittington","year":"2004","journal-title":"Am J Respir Cell Mol Biol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1097\/SHK.0000000000000900","article-title":"Interleukin-22 prevents microbial dysbiosis and promotes intestinal barrier regeneration following acute injury","volume":"48","author":"Hammer","year":"2017","journal-title":"Shock"},{"key":"B19","doi-asserted-by":"publisher","first-page":"805","DOI":"10.3389\/fimmu.2017.00805","article-title":"CCR6 deficiency impairs IgA production and dysregulates antimicrobial peptide production, altering the intestinal flora","volume":"8","author":"Lin","year":"2017","journal-title":"Front Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/mi.2016.38","article-title":"IL-22-induced antimicrobial peptides are key determinants of mucosal vaccine-induced protection against H. pylori in mice","volume":"10","author":"Moyat","year":"2017","journal-title":"Mucosal Immunol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"3417","DOI":"10.4049\/jimmunol.1700003","article-title":"Antigen-presenting human gammadelta T cells promote intestinal CD4(+) T cell expression of IL-22 and mucosal release of calprotectin","volume":"198","author":"Tyler","year":"2017","journal-title":"J Immunol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"6911","DOI":"10.1128\/JVI.02943-12","article-title":"Interleukin-22 reduces lung inflammation during influenza A virus infection and protects against secondary bacterial infection","volume":"87","author":"Ivanov","year":"2013","journal-title":"J Virol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1093\/infdis\/jit495","article-title":"Interleukin 22 inhibits intracellular growth of Mycobacterium tuberculosis by enhancing calgranulin A expression","volume":"209","author":"Dhiman","year":"2014","journal-title":"J Infect Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1194\/jlr.M044305","article-title":"IL-22 is induced by S100\/calgranulin and impairs cholesterol efflux in macrophages by downregulating ABCG1","volume":"55","author":"Chellan","year":"2014","journal-title":"J Lipid Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"4376","DOI":"10.1073\/pnas.0711159105","article-title":"Mycobacterial persistence requires the utilization of host cholesterol","volume":"105","author":"Pandey","year":"2008","journal-title":"Proc Natl Acad Sci USA."},{"key":"B26","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1093\/infdis\/jiu106","article-title":"Activation of Type 3 innate lymphoid cells and interleukin 22 secretion in the lungs during Streptococcus pneumoniae infection","volume":"210","author":"Van Maele","year":"2014","journal-title":"J Infect Dis."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.4049\/jimmunol.1600528","article-title":"Critical role of IL-22\/IL22-RA1 signaling in pneumococcal pneumonia","volume":"197","author":"Trevejo-Nunez","year":"2016","journal-title":"J Immunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1128\/IAI.01085-13","article-title":"Candida albicans airway exposure primes the lung innate immune response against Pseudomonas aeruginosa infection through innate lymphoid cell recruitment and interleukin-22-associated mucosal response","volume":"82","author":"Mear","year":"2014","journal-title":"Infect Immun."},{"key":"B29","doi-asserted-by":"publisher","first-page":"11010","DOI":"10.1038\/s41598-017-11518-0","article-title":"Interleukin-22 level is negatively correlated with neutrophil recruitment in the lungs in a Pseudomonas aeruginosa pneumonia model","volume":"7","author":"Broquet","year":"2017","journal-title":"Sci Rep."},{"key":"B30","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1183\/09031936.00215114","article-title":"Neutrophil proteases alter the interleukin-22-receptor-dependent lung antimicrobial defence","volume":"46","author":"Guillon","year":"2015","journal-title":"Eur Respir J."},{"key":"B31","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/mi.2016.40","article-title":"Interleukin-22 protects against non-typeable Haemophilus influenzae infection: alteration during chronic obstructive pulmonary disease","volume":"10","author":"Sharan","year":"2017","journal-title":"Mucosal Immunol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e57379","DOI":"10.1371\/journal.pone.0057379","article-title":"IL-22 is mainly produced by IFNgamma-secreting cells but is dispensable for host protection against Mycobacterium tuberculosis infection","volume":"8","author":"Behrends","year":"2013","journal-title":"PLoS ONE"},{"key":"B33","doi-asserted-by":"publisher","first-page":"4378","DOI":"10.4049\/jimmunol.0903416","article-title":"Redundant and pathogenic roles for IL-22 in mycobacterial, protozoan, and helminth infections","volume":"184","author":"Wilson","year":"2010","journal-title":"J Immunol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1086\/592448","article-title":"Severe tuberculosis induces unbalanced up-regulation of gene networks and overexpression of IL-22, MIP-1alpha, CCL27, IP-10, CCR4, CCR5, CXCR3, PD1, PDL2, IL-3, IFN-beta, TIM1, and TLR2 but low antigen-specific cellular responses","volume":"198","author":"Qiu","year":"2008","journal-title":"J Infect Dis."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.4049\/jimmunol.180.3.1962","article-title":"Distinct, specific IL-17- and IL-22-producing CD4+ T cell subsets contribute to the human anti-mycobacterial immune response","volume":"180","author":"Scriba","year":"2008","journal-title":"JImmunol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.tube.2011.06.009","article-title":"Predominance of interleukin-22 over interleukin-17 at the site of disease in human tuberculosis","volume":"91","author":"Matthews","year":"2011","journal-title":"Tuberculosis"},{"key":"B37","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/path.5013","article-title":"Interleukin-17 regulates matrix metalloproteinase activity in human pulmonary tuberculosis","volume":"244","author":"Singh","year":"2018","journal-title":"J Pathol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1164\/rccm.201210-1934OC","article-title":"Regulatory T cells attenuate mycobacterial stasis in alveolar and blood-derived macrophages from patients with tuberculosis","volume":"187","author":"Semple","year":"2013","journal-title":"Am J Respir Crit Care Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"e1000789","DOI":"10.1371\/journal.ppat.1000789","article-title":"Differentiation, distribution and gammadelta T cell-driven regulation of IL-22-producing T cells in tuberculosis","volume":"6","author":"Yao","year":"2010","journal-title":"PLoS Pathog."},{"key":"B40","doi-asserted-by":"publisher","first-page":"e0167471","DOI":"10.1371\/journal.pone.0167471","article-title":"Differential cytokine gene expression in granulomas from lungs and lymph nodes of cattle experimentally infected with aerosolized Mycobacterium bovis","volume":"11","author":"Palmer","year":"2016","journal-title":"PLoS ONE"},{"key":"B41","doi-asserted-by":"publisher","first-page":"e1003077","DOI":"10.1371\/journal.ppat.1003077","article-title":"Global gene transcriptome analysis in vaccinated cattle revealed a dominant role of IL-22 for protection against bovine tuberculosis","volume":"8","author":"Bhuju","year":"2012","journal-title":"PLoS Pathog."},{"key":"B42","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/j.1365-2249.2011.04520.x","article-title":"Comparison of interferon-gamma-, interleukin (IL)-17- and IL-22-expressing CD4 T cells, IL-22-expressing granulocytes and proinflammatory cytokines during latent and active tuberculosis infection","volume":"167","author":"Cowan","year":"2012","journal-title":"Clin Exp Immunol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/srep00020","article-title":"An SNP selection strategy identified IL-22 associating with susceptibility to tuberculosis in Chinese","volume":"1","author":"Zhang","year":"2011","journal-title":"Sci Rep."},{"key":"B44","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1513\/AnnalsATS.201305-112OC","article-title":"Type 2 diabetes mellitus coincident with pulmonary tuberculosis is associated with heightened systemic type 1, type 17, and other proinflammatory cytokines","volume":"10","author":"Kumar","year":"2013","journal-title":"Ann Am Thorac Soc."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1093\/infdis\/jiu329","article-title":"Diminished systemic and antigen-specific Type 1, Type 17, and other proinflammatory cytokines in diabetic and prediabetic individuals with latent Mycobacterium tuberculosis infection","volume":"210","author":"Kumar","year":"2014","journal-title":"J Infect Dis."},{"key":"B46","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.tube.2015.06.004","article-title":"Type 2 diabetes - Tuberculosis co-morbidity is associated with diminished circulating levels of IL-20 subfamily of cytokines","volume":"95","author":"Kumar","year":"2015","journal-title":"Tuberculosis"},{"key":"B47","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/j.1365-3083.2011.02512.x","article-title":"ESAT-6- and CFP-10-specific Th1, Th22 and Th17 cells in tuberculous pleurisy may contribute to the local immune response against Mycobacterium tuberculosis infection","volume":"73","author":"Qiao","year":"2011","journal-title":"Scand J Immunol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"94650","DOI":"10.18632\/oncotarget.21841","article-title":"Matrix metalloproteinase MMP9 maintains epithelial barrier function and preserves mucosal lining in colitis associated cancer","volume":"8","author":"Pujada","year":"2017","journal-title":"Oncotarget"},{"key":"B49","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.tube.2013.12.003","article-title":"Anti-tuberculosis treatment enhances the production of IL-22 through reducing the frequencies of regulatory B cell","volume":"94","author":"Zhang","year":"2014","journal-title":"Tuberculosis"},{"key":"B50","doi-asserted-by":"publisher","first-page":"e0190189","DOI":"10.1371\/journal.pone.0190189","article-title":"Neutrophil predominance in bronchoalveolar lavage fluid is associated with disease severity and progression of HRCT findings in pulmonary Mycobacterium avium infection","volume":"13","author":"Inomata","year":"2018","journal-title":"PLoS ONE"},{"key":"B51","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.chest.2017.04.155","article-title":"Defining a research agenda to address the converging epidemics of tuberculosis and diabetes: part 1: epidemiology and clinical management","volume":"152","author":"Critchley","year":"2017","journal-title":"Chest"},{"key":"B52","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.chest.2017.02.032","article-title":"Defining a research agenda to address the converging epidemics of tuberculosis and diabetes: part 2: underlying biologic mechanisms","volume":"152","author":"Ronacher","year":"2017","journal-title":"Chest"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-9-81","article-title":"The impact of diabetes on tuberculosis treatment outcomes: a systematic review","author":"Baker","year":"2011","journal-title":"BMC Med."},{"key":"B54","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nature13564","article-title":"Interleukin-22 alleviates metabolic disorders and restores mucosal immunity in diabetes","volume":"514","author":"Wang","year":"2014","journal-title":"Nature"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1038\/nm.3705","article-title":"Glycemic control in diabetes is restored by therapeutic manipulation of cytokines that regulate beta cell stress","volume":"20","author":"Hasnain","year":"2014","journal-title":"Nat Med."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02209\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T04:42:31Z","timestamp":1537850551000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02209\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,25]]},"references-count":55,"alternative-id":["10.3389\/fimmu.2018.02209"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.02209","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,25]]},"article-number":"2209"}}